Heartport Stock Up 97% In September On Acquisition Interest, New Products
This article was originally published in The Gray Sheet
Executive Summary
Continued strong interest in minimally invasive surgery by cardiac surgeons, acquisition of competitors in the sector, a new CEO and several recent product introductions appeared to help stimulate a 97.3% gain in Heartport stock in September. The issue gained 2-1/4 points to close the month at 4-9/16.